AWARD
A -- Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity
- Notice Date
- 9/22/2022 7:17:27 AM
- Notice Type
- Award Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95022D00019
- Archive Date
- 10/05/2022
- Point of Contact
- Shaun Rostad, Phone: 3014436677, Joshua T. Lazarus, Phone: 3014436677
- E-Mail Address
-
shaun.rostad@nih.gov, Josh.Lazarus@nih.gov
(shaun.rostad@nih.gov, Josh.Lazarus@nih.gov)
- Award Number
- 75N95022D00019
- Award Date
- 09/20/2022
- Awardee
- Lovelace Biomedical Research Institute NM 87108-5129 USA
- Award Amount
- 6500000.00
- Description
- NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On September 20, 2022; in response to the requirements of Solicitation 75N95022R00012, the National Institute on Drug Abuse (NIDA) awarded an Indefinite Delivery/Indefinite Quantity Contract No. 75N95022D00019 to Lovelace Biomedical Research Institute for the Assessment of Potential Treatments for Drug-induced Respiratory Depression and Overdose Toxicity. The ordering period for cost reimbursement plus fixed fee task orders will be from September 26, 2022 � September 25, 2027. The minimum order amount shall be $24,000 and the ceiling shall be $6,500,000 over the five-year ordering period.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/61ed1525d1404b02981cda8523916070/view)
- Record
- SN06474373-F 20220924/220922230111 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |